Xiaocheng Li

Xiaocheng Li

Auto-generated profile, based on publicly available information

Xiaocheng Li

School of Bioscience and Technology, Weifang Medical University, Weifang, Shandong Province, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Cancer Letters
Verified
Journal Article
Closed access
XLXiaocheng Li
Xiaocheng Li
WDWenbin Diao
Wenbin Diao
HXHantao Xue
Hantao Xue
FWFei Wu
Fei Wu
WWWeiyu Wang
Weiyu Wang
ZGZhiqin Gao
Zhiqin Gao

1 November 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
FWFei Wu
Fei Wu
HXHantao Xue
Hantao Xue
XLXiaocheng Li
Xiaocheng Li
WDWenbin Diao
Wenbin Diao
BJBin Jiang
Bin Jiang
GZGao Zhi-Qin
Gao Zhi-Qin
Hepatocellular carcinoma (HCC), a common malignancy in China and globally, is primarily treated through surgical resection and liver transplantation, with chemotherapy as a significant synergistic option. Adenine (Ade), a nucleobase, exhibits antitumor effects by blocking human hepatic carcinoma cells in S phase and inhibiting tumor cell proliferation. However, its use is limited owing to its low solubility, poor targeting ability, and nephrotoxicity. Therefore, liver-targeting drug delivery systems have attracted considerable attention for the treatment of HCC. In this study, we explored the liver-targeting efficacy and antitumor effect of adenine-loaded glycyrrhetinic acid-modified hyaluronic acid (Ade/GA-HA) nanoparticles in vitro and in vivo. The GA-HA nanoparticles possessed obvious targeting specificity toward liver cancer cells, which was mainly achieved by the specific binding of the GA ligand to the GA receptor that was highly expressed on the liver cell membrane. In vitro and in vivo results showed that Ade/GA-HA nanoparticles could inhibit liver cancer cell proliferation and migration, promote apoptosis, and significantly inhibit the growth of tumor tissues. Altogether, this study is the first to successfully demonstrate that the targeting activity and antitumor effect of Ade against HCC are enhanced by using GA-HA nanoparticles in vitro and in vivo.